Transgene Biotek Ltd
BSE : 526139|NSE : None|ISIN : INE773D01018
Transgene Biotek Ltd Company History
Transgene Biotek is in the business of Research & Development.
2011
2012
2013
2014
2011
Company has set up a wholly-owned subsidiary Company in Hong Kong by the name "Transgene Biotek HK Ltd.".
2011
2012
"Transgene readying to launch one of its block-buster drugs - TrabiDHA (DHA) formulations."
2012
2013
Transgene signs a Joint Venture agreement with Atral Cipan of Portugal involving the technology transfer of Tacrolimus by Transgene.
Transgene Biotek becomes the worldÂs first company to create and launch 50% algal DHA oil, and 20% algal DHA powder.
2013
2014
S/Sri Sarang Subhash Puranik and Shyam Shankar Das would be appointed as Directors of the company.
2014
